Search results
The 7 Most Undervalued Under-$50 Stocks to Buy in June 2024
InvestorPlace· 6 days agoFor many investors, especially those who are just building a portfolio, undervalued stocks under $50...
Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee...
Morningstar· 3 days ago(NYSE: AWI), ATI, Inc. (NYSE: ATI), Weyerhaeuser Company (NYSE: WY), and General Electric...
Replimune (REPL) Gains on Positive Data From Melanoma Study
Zacks via Yahoo Finance· 7 days agoReplimune's (REPL) lead pipeline candidate RP1, in combination with Opdivo, leads to an overall...
Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
Zacks via Yahoo Finance· 4 days agoGeron's (GERN) shares rise on approval of its first drug. The FDA approves imetelstat for the...
FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug
Benzinga via AOL· 7 days agoOn Thursday, the FDA approved Geron Corporation's (NASDAQ:GERN) Rytelo (imetelstat) for adult...
7 Stocks Warren Buffett Has Sold in the Past Year (and You Should Too)
InvestorPlace· 4 days agoThe Oracle of Omaha is by far the most well-known long-term investor we have alive today, and if you...
Geron stock steady as analysts maintain 'buy' rating with $10 target By Investing.com
Investing.com· 7 days agoOn Friday, TD (TSX:TD) Cowen reaffirmed its confidence in Geron (NASDAQ:GERN) Corporation...
Geron surges after winning first US FDA approval for blood disorder drug
Reuters· 7 days ago, opens new tab surged more than 30% on Friday, a day after the company gained its first approval...
Morning Brew: GameStop Tumbles After Earnings Miss, TSMC Reports
Guru Focus· 7 days agoS&P futures vs fair value: +2.00. Nasdaq futures vs fair value: +31.00.The S&P 500 futures are up...